lorlatinib,crizotinib
pfizer
['nsclc', 'sclc', 'pfizer']
an analysis of the phase 3 crown study identifying molecular correlates of response through comprehensive molecular profiling of ctdna &amp; tumor tissue in pts w/ alk+ adv #nsclc receiving a 1st-gen or 3rd-gen alk tki is being presented at #asco22 9070 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ